Sanofi to start human trials of its second Covid vaccine candidate | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
May 30, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, MAY 30, 2025
Sanofi to start human trials of its second Covid vaccine candidate

Coronavirus chronicle

Hindustan Times
12 March, 2021, 02:10 pm
Last modified: 12 March, 2021, 02:12 pm

Related News

  • Novavax signs Covid-19 license deal with Sanofi, removes doubt about business viability
  • Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • WHO provides 11 lakh bivalent vaccines to Bangladesh: Minister
  • Incepta Pharma abandons Covid vaccine plan
  • AstraZeneca, Moderna recipients to receive Pfizer vaccine to mix-and-match

Sanofi to start human trials of its second Covid vaccine candidate

Sanofi and US company Translate Bio are developing the vaccine based on messenger RNA technology

Hindustan Times
12 March, 2021, 02:10 pm
Last modified: 12 March, 2021, 02:12 pm
Sanofi to start human trials of its second Covid vaccine candidate

French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second Covid-19 vaccine, with its first still in the testing phase after having fallen behind in development.

Sanofi and US company Translate Bio are developing the vaccine based on messenger RNA technology.

The phase 1 and 2 trials aim to verify that the vaccine is not dangerous and to provide initial information on its effectiveness.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Phase 3 would be carried out on many more patients to determine its effectiveness.

The first trials will include 415 people, with inital results expected in the third quarter.

Messenger RNA technology is also used in the Pfizer/BioNTech and Moderna vaccines, already authorised in the European Union, the United States and elsewhere.

It is the second vaccine developed by Sanofi against the coronavirus.

An earlier candidate, developed with Britain's GSK, is recombinant protein-based, but its development is several months behind schedule and testing is only in phase 2, with hopes to launch it in late 2021.

Top News

Sanofi / covid-19 vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • BNP Standing Committee Member Mirza Abbas and other senior party leaders pay tributes at the grave of BNP founder and former president Ziaur Rahman at Chandrima Udyan in the capital’s Sher-e-Bangla Nagar on 30 May 2025. Photo: BNP Media Cell
    Only Yunus doesn’t want polls, says Mirza Abbas slamming CA for 'slandering BNP'
  • The continuous heavy rain caused waterlogging on several roads in Dhaka. These photos were captured from Dhanmondi Hawkers Market area on  30 May 2025. Photo: Rajib Dhar/TBS
    In photos: Continuous rain for 2 days causes waterlogging across Dhaka
  • Photo: Collected
    Over 5,000 mobile towers down as depression-triggered storms disrupt telecom services

MOST VIEWED

  • Photo: Courtesy
    New notes featuring historic, archaeological structures of Bangladesh to be circulated from 1 June
  • Two Memoranda of Understanding were signed at the seminar titled “Bangladesh Seminar on Human Resources,” in Tokyo on 29 May 2025. Photo: CA Press Wing
    Japan to recruit 100,000 Bangladeshi workers over next 5 years
  • Representational Photo: Collected
    Country's all jewellery shops to remain indefinitely closed in protest of VP Reponul's arrest: Bajus
  • BAT Bangladesh has to vacate Mohakhali HQ as SC rejects lease appeal
    BAT Bangladesh has to vacate Mohakhali HQ as SC rejects lease appeal
  • Illustration: TBS
    Bangladesh repays $3.5b foreign debt in 10 months of FY25
  • Khondoker Rashed Maqsood. File Photo: Collected
    Investors urge removal of BSEC chairman in meeting with CA’s special assistant, submit list of demands

Related News

  • Novavax signs Covid-19 license deal with Sanofi, removes doubt about business viability
  • Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • WHO provides 11 lakh bivalent vaccines to Bangladesh: Minister
  • Incepta Pharma abandons Covid vaccine plan
  • AstraZeneca, Moderna recipients to receive Pfizer vaccine to mix-and-match

Features

Photo collage of the sailors and their catch. Photos: Shahid Sarkar

Between sky and sea: The thrilling life afloat on a fishing ship

2h | Features
For hundreds of small fishermen living near this delicate area, sustainable fishing is a necessity for their survival. Photo: Syed Zakir Hossain

World Ocean Day: Bangladesh’s ‘Silent Island’ provides a fisheries model for the future

19h | The Big Picture
The university will be OK. But will the US? Photo: Bloomberg

A weaker Harvard is a weaker America

19h | Panorama
The Botanical Garden is a refuge for plant species, both native and exotic. Photo: Mehedi Hasan/TBS

The hidden cost of 'development' in the Botanical Garden

19h | Panorama

More Videos from TBS

Record migrant deaths in 2024

Record migrant deaths in 2024

16h | Podcast
Govt likely to trim subsidies in new budget

Govt likely to trim subsidies in new budget

26m | TBS Insight
News of The Day, 29 MAY 2025

News of The Day, 29 MAY 2025

18h | TBS News of the day
Businesses set for relief as interim govt eyes major tax & fine cuts

Businesses set for relief as interim govt eyes major tax & fine cuts

21h | TBS Insight
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net